Groowe Groowe / Newsroom / ORIC
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ORIC News

Oric Pharmaceuticals, Inc. Common Stock

ORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting

globenewswire.com
ORIC

ORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting

globenewswire.com
ORIC

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
ORIC

Form 8-K

sec.gov
ORIC

Form 8-K

sec.gov
ORIC

ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates

globenewswire.com
ORIC

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
ORIC

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

globenewswire.com
ORIC

Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff

prnewswire.com
ONCY NRIX ERAS FHTX ORIC

ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones

globenewswire.com
ORIC